Perrigo Company plc (NYSE: PRGO), an Ireland-based global provider of Consumer Self-Care Products, announced on Wednesday that its board of directors has declared a quarterly dividend of USD0.290 per share, payable on September 16, 2025, to shareholders of record on August 29, 2025. This amount is unchanged from the previous quarterly dividend.
Perrigo Company plc is a pure-play self-care company with over a century of experience in providing health and wellness solutions to consumers, primarily in North America and Europe.
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Ridgetech reports net income of USD10.20m in fiscal year 2025
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea